Secukinumab in a patient with sarcoidosis

Thumbnail

View/Open

Date

2020

Author

Kobak, Senol
Gungen, Adil Can
Dogan Gungen, Belma
Tutpinar, Yildiray
Guler, Mehtap

Metadata

Show full item record

Citation

Kobak, S., Gungen, A. C., Gungen, B. D., Tutpinar, Y., & Guler, M. (2020). Secukinumab in a patient with sarcoidosis. Scandinavian Journal of Rheumatology, 1-2.

Abstract

Sarcoidosis is a systemic granulomatous disease, characterized by non-caseating granuloma formation. It usually involves the lungs, but may also affect the eyes, heart, skin, and musculoskeletal system. The pathogenesis is not well known, but it is generally accepted as Th1 disease. The role of Th17-induced cytokines in the development of sarcoid granuloma has been reported.

Source

Scandinavian Journal of Rheumatology

URI

https://doi.org/10.1080/03009742.2020.1784460
https://hdl.handle.net/20.500.12713/1010

Collections